Werbung
Werbung
NVCR
NovoCure Limited Ordinary Shares
14.77
USDGesponsert
+0.36
+2.47%
08. Jan., 15:25 UTC -5
Offen
NVCR Ergebnisberichte
Positives Überraschungsverhältnis
NVCR übertreffen die 23 der letzten 40Schätzungen.
57%
Nächster Bericht
Datum des nächsten Berichts
23. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$172.30M
/-$0.40
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+3.05%
/+21.21%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+6.84%
/-34.43%
NovoCure Limited Ordinary Shares earnings per share and revenue
On 30. Okt. 2025, NVCR reported earnings of -0.33 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 23.15% surprise. Revenue reached 167.20 million, compared to an expected 162.37 million, with a 2.98% difference. The market reacted with a -4.90% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 analysts forecast an EPS of -0.40 USD, with revenue projected to reach 172.30 million USD, implying an increase of 21.21% EPS, and increase of 3.05% in Revenue from the last quarter.
FAQ
What were NovoCure Limited Ordinary Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, NovoCure Limited Ordinary Shares reported EPS of -$0.33, beating estimates by 23.15%, and revenue of $167.20M, 2.98% above expectations.
How did the market react to NovoCure Limited Ordinary Shares's Q3 2025 earnings?
The stock price moved down -4.9%, changed from $13.48 before the earnings release to $12.82 the day after.
When is NovoCure Limited Ordinary Shares expected to report next?
The next earning report is scheduled for 23. Feb. 2026.
What are the forecasts for NovoCure Limited Ordinary Shares's next earnings report?
Based on 10
analysts, NovoCure Limited Ordinary Shares is expected to report EPS of -$0.40 and revenue of $172.30M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung